跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,331 条关于
“Kashiv Biosciences”
全部
2,331
临床试验
76
药物
528
机构
272
资讯
1,455
2年前
Kashiv BioSciences and Amneal Pharmaceuticals Partner for Omalizumab Biosimilar
11个月前
Kashiv BioSciences and JAMP Pharma Launch Neutropenia Biosimilars in Canada
4个月前
Amneal Pharmaceuticals Acquires Kashiv BioSciences for $750 Million to Create Global Biosimilar Leader
去年
Kashiv BioSciences Partners with MS Pharma for MENA Launch of Omalizumab Biosimilar ADL-018
8个月前
Kashiv BioSciences Secures $77 Million Financing to Build India's Largest Single-Use Biologics Manufacturing Facility
去年
Kashiv Biosciences' Abatacept Biosimilar KSHB002 Meets Primary Endpoints in Phase I Trial
11个月前
Amneal Submits BLA for Omalizumab Biosimilar to Challenge $4.1 Billion XOLAIR Market
4年前
FDA Approves Fylnetra, Fifth Biosimilar of Neulasta, for Febrile Neutropenia
去年
Alvotech's Xolair Biosimilar AVT23 Achieves Positive Phase III Results and UK Regulatory Acceptance
上个月
Amneal Completes Kashiv Acquisition, Building an Integrated Global Biosimilars Platform
第 1 页,共 146 页
上一页
下一页